Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 0,32 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hypromellose 0,5 % + phenylephrin 0,12 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
kunstige hypotoniske øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 0,3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hydroxypropyl methylcellulose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose adverse reaction |
Causative agent |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose eye drops adverse reaction |
Causative agent |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Allergy to hypromellose |
Causative agent |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
allergi over for øjendråber indeholdende hypromellose |
Causative agent |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
hydroxypropylmethylcellulose 0,32 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hypromellose 0,5 % + phenylephrin 0,12 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Hypromellose 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Hydroxypropylmethylcellulose 1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose i balanceret saltopløsning 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
kunstige hypotoniske øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 0,3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 2 % injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 1,8 % injektionsvæske, opløsning i fyldt injektionssprøjte a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 0,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylmethylcellulose 2,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
hydroxypropylcellulose 5 mg/enhed |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
dexamethason 0,1 % + hypromellose 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
Product containing glucose and glutathione and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Allergy to hypromellose |
Causative agent |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
allergi over for øjendråber indeholdende hypromellose |
Causative agent |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 3 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 3 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Dextran 70- and hypromellose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing only dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Glucose and glutathione and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing only hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing only hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing only hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing only dextran 70 and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 3.2 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Hypromellose 3.2 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing only dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone and hypromellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing dexamethasone and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |